Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
1.
Ann Clin Lab Sci ; 51(4): 451-460, 2021 Jul.
Article in English | MEDLINE | ID: mdl-34452883

ABSTRACT

OBJECTIVE: To reduce the incidence of Opioid Use Disorder (OUD), multiple guidelines recommend assessing the risk of OUD prior to prescribing oral opioids. Although subjective risk assessments are available to help classify subjects at risk for OUD, we are aware of no clinically validated objective risk assessment tools. An objective risk assessment based on genetics may help inform shared decision-making prior to prescribing short-duration oral opioids. METHODS: A multicenter, observational cohort of adults exposed to prescription oral opioids for 4-30 days was conducted to determine the performance of an OUD classifier derived from machine learning (ML). From this cohort, the demographics of the U.S. adult opioid-prescribed population were used to create a blinded, random, representative group of subjects (n=385) for analysis to accurately estimate the performance characteristics in the intended use population. Genotyping was performed via a qualitative SNP microarray on DNA extracted from buccal samples. RESULTS: In the study subjects, the classifier demonstrated 82.5% sensitivity (95% confidence intervals: 76.1%-87.8%) and 79.9% specificity (73.7-85.2%), with no statistically significant differences in clinical performance observed based on gender, age, length of follow-up from opioid exposure, race, or ethnicity. CONCLUSION: This study demonstrates an ML classifier may provide additional objective information regarding a patient's risk of developing OUD. This information may enable subjects and healthcare providers to make more informed decisions when considering the use of oral opioids.


Subject(s)
Analgesics, Opioid/adverse effects , Genetic Markers , Machine Learning , Opioid-Related Disorders/epidemiology , Risk Assessment/methods , Adolescent , Adult , Aged , Aged, 80 and over , Female , Follow-Up Studies , Genotype , Humans , Male , Middle Aged , Opioid-Related Disorders/etiology , Opioid-Related Disorders/genetics , Opioid-Related Disorders/pathology , Prognosis , Prospective Studies , United States/epidemiology , Young Adult
2.
Adm Policy Ment Health ; 34(3): 315-8, 2007 May.
Article in English | MEDLINE | ID: mdl-17115284

ABSTRACT

Involuntary outpatient treatment is one of the most controversial areas in public psychiatry. There are cogent arguments and strong emotions both for and against the use of it. Yet there is violent behavior towards others by individuals with mental illness who reside in the community that is not managed well even when recognized as highly likely. For individuals already in the community mental health system, the ability to keep them in treatment, even against their will, is necessary in some instances to decrease the likelihood of them engaging in outwardly directed violent behavior.


Subject(s)
Ambulatory Care , Commitment of Mentally Ill , Professional Competence , Violence/prevention & control , Humans , Mental Disorders , United States
SELECTION OF CITATIONS
SEARCH DETAIL
...